TABLE 5.
hsp involvement in human autoimmune diseases
| Disease | hsp-specific responses | Reference(s) |
|---|---|---|
| RA | Antibodies specific for mycobacterial hsp60 | 188 |
| Binding of hsp60-specific antibodies to synovial tissue of patients with RA | 55 | |
| Raised expression of self-hsp60 in inflamed synovium in juvenile chronic RA | 30 | |
| Response of cross-reactive αβ T cells from inflamed sites to mycobacterial hsp60 and human hsp60 | 173 | |
| Cross-reactive αβ T cells from synovial fluid of patients with juvenile chronic RA specific for conserved regions of the mycobacterial and human hsp60 | 56, 112 | |
| T- and B-cell responses to mycobacterial hsp60 in juvenile RA | 50 | |
| γδ T cells in synovial fluid of RA reactive for mycobacterial hsp60 | 121 | |
| Response of cross-reactive γδ T cell clone from synovial fluid to mycobacterial and human hsp60 | 104 | |
| Overexpression of hsp60 on synovial fluid lymphocytes from RA patients | 245 | |
| Localization of mycobacterial hsp60-reactive B cells within affected joints | 240 | |
| Correlation of T-cell responses to human hsp60 in early course of oligoarticular RA with disease remission | 223 | |
| T cells of synovial fluid and peripheral blood reactive for mycobacterial hsp60 | 40 | |
| SLE | Overexpression of hsp90 in B and T cells of SLE patients | 72 |
| Raised antibody levels to hsp90 in a significant group of SLE patients | 44 | |
| Antibodies reactive with hsp90 in childhood-onset SLE | 45 | |
| MS | hsp70-specific antibodies in serum and cerebrospinal fluid of MS patients | 24 |
| Detection of hsp70-reactive and hsp60-reactive αβ T cells in spinal fluid of MS patients | 25, 242 | |
| Correlation of overexpression of hsp60 by immature oligodendrocytes with localization of γδ T cells | 256 | |
| Accumulation of γδ T cells in areas of demyelination | 256 | |
| Detection of γδ T cells in acute lesions of MS | 303 | |
| Induction of hsp expression in oligodendrocytes in vitro | 86 | |
| T cells specific for the small hsp, alpha B-crystallin, in MS patients | 294 | |
| Increased expression of alpha B-crystallin in astrocytes and oligodendrocytes in MS patients | 294 | |
| Increased expression of alpha B-crystallin in early stage of lesional development in a subpopulation of oligodendrocytes | 14 | |
| Reactive arthritis | Response of αβ T cells from synovial fluid to human hsp60, to stressed host cells, and to mononuclear cells isolated from inflamed joints | 112 |
| Selective stimulation of γδ T cells by in vitro stimulation with hsp60 | 113 | |
| Recognition of HLA-B27-restricted chlamydial hsp60 peptide by CD8 T cells derived from synovial fluid of patient with chlamydia-induced reactive arthritis | 184 | |
| Identification of a T-cell epitope within the chlamydial hsp60 recognized by a T-cell clone isolated from a patient with reactive arthritis | 52 | |
| Kawasaki disease | Antibodies to mycobacterial hsp60 and autoantibodies to epitopes of human hsp60-specific antibodies | 307 |
| Behcet’s disease | hsp60-specific antibodies in serum from patients | 170 |
| T-cell response to self-hsp60 | 217 | |
| Stimulation of T cells from patients with Behcet’s disease by self hsp60 peptides | 138 | |
| γδ T cells of patients reactive to mycobacterial hsp60 peptides | 109 | |
| Psoriasis | Antibodies specific for mycobacterial hsp60 | 229 |
| Atherosclerosis | hsp60-specific antibodies | 304 |
| Correlation of intensity of hsp60 expression with recruitment of hsp-reactive T cells | 159 | |
| Lysis of macrophages expressing hsp60 from patients by antibodies against self-hsp60 | 247 | |
| Systemic sclerosis | Antibodies specific for mycobacterial hsp60 | 50 |
| Chronic gastritis | Colocalization of γδ T cells with hsp60 expression of inflammatory gastritis epithelium | 71 |
| Hashimoto’s thyroiditis | High expression of self-hsp60 in follicular cells from patients | 162 |